• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锇(II)——与钌(II)——芳基碳水化合物抗癌化合物:相似与不同。

Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.

机构信息

University of Vienna, Institute of Inorganic Chemistry, Waehringer Str. 42, A-1090, Vienna, Austria.

出版信息

Dalton Trans. 2010 Aug 21;39(31):7345-52. doi: 10.1039/c003085f. Epub 2010 Jul 2.

DOI:10.1039/c003085f
PMID:20601976
Abstract

The synthesis and in vitro anticancer activity of Os(II)-arene complexes with carbohydrate-derived phosphite co-ligands are reported. The compounds were characterized by standard methods and the molecular structure of dichlorido(eta(6)-p-cymene)(3,5,6-bicyclophosphite-1,2-O-isopropylidene-alpha-D-glucofuranoside)osmium(II) was determined by X-ray diffraction analysis. Complexes with chlorido leaving groups undergo hydrolysis by consecutive formation of aqua compounds, followed by cleavage of a P-O bond of sugar phosphite ligands, as demonstrated by NMR studies. These observations are similar to those of analogous Ru(II)-arene complexes; however the rate of hydrolysis is very slow for osmium compounds. The complexes with oxalato leaving groups resist hydrolysis; no hydrolytic species were detected by (31)P{(1)H} NMR spectroscopy over several days. Within this series of Os compounds, in vitro anticancer activity is highest for the most lipophilic chlorido complex dichlorido(eta(6)-p-cymene)(3,5,6-bicyclophosphite-1,2-O-cyclohexylidene-alpha-D-glucofuranoside)osmium(II).

摘要

报道了具有碳水化合物衍生亚膦酸酯共配体的 Os(II)-芳基配合物的合成及体外抗癌活性。通过标准方法对化合物进行了表征,并通过 X 射线衍射分析确定了二氯(η(6)-对-甲基苯)(3,5,6-双环膦酸酯-1,2-O-异丙叉-α-D-葡萄糖呋喃糖苷)合锇(II)的分子结构。具有氯离去基团的配合物通过连续形成水合化合物进行水解,随后糖亚膦酸酯配体的 P-O 键断裂,这一点通过 NMR 研究得到证实。这些观察结果与类似的 Ru(II)-芳基配合物相似;然而,对于锇化合物,水解的速率非常慢。具有草酰根离去基团的配合物抵抗水解;在数天内,通过(31)P{(1)H}NMR 光谱未检测到水解产物。在这一系列 Os 化合物中,最亲脂性的氯配合物二氯(η(6)-对-甲基苯)(3,5,6-双环膦酸酯-1,2-O-环己叉-α-D-葡萄糖呋喃糖苷)合锇(II)具有最高的体外抗癌活性。

相似文献

1
Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.锇(II)——与钌(II)——芳基碳水化合物抗癌化合物:相似与不同。
Dalton Trans. 2010 Aug 21;39(31):7345-52. doi: 10.1039/c003085f. Epub 2010 Jul 2.
2
From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.具有碳水化合物衍生共配体的从水解不稳定到水解稳定的 Ru(II)-芳环抗癌配合物。
J Inorg Biochem. 2011 Feb;105(2):224-31. doi: 10.1016/j.jinorgbio.2010.10.004. Epub 2010 Oct 14.
3
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.在生理条件下调节锇(II)和钌(II)芳烃配合物的反应活性。
J Am Chem Soc. 2006 Feb 8;128(5):1739-48. doi: 10.1021/ja055886r.
4
Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.通过 N,O-螯合配体调节锇芳烃配合物的水解水相化学以实现癌细胞毒性。
J Am Chem Soc. 2007 Mar 21;129(11):3348-57. doi: 10.1021/ja068335p. Epub 2007 Feb 24.
5
Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.酰胺键异构作为有机金属锇和钌抗癌配合物的活性开关。
J Med Chem. 2009 Dec 10;52(23):7753-64. doi: 10.1021/jm900731j.
6
Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.含吡啶酸盐衍生物的有机金属锇(II)芳族抗癌配合物。
Inorg Chem. 2009 Feb 16;48(4):1753-62. doi: 10.1021/ic8020222.
7
Anticancer activity of opened arene ruthenium metalla-assemblies.开芳环钌金属配合物的抗癌活性。
Dalton Trans. 2010 Jun 14;39(22):5272-7. doi: 10.1039/c001521k. Epub 2010 May 4.
8
Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.钌(II)芳烃配合物稳定的硒醌:合成、结构与细胞毒性
Chemistry. 2014 May 5;20(19):5795-801. doi: 10.1002/chem.201304991. Epub 2014 Mar 26.
9
Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?3-羟基-2(1H)-吡啶酮的 M(II)-芳基配合物与生物分子的反应性是否是抗癌活性的决定因素?
Inorg Chem. 2010 Sep 6;49(17):7953-63. doi: 10.1021/ic1009785.
10
Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.高活性中性钌(II)芳环配合物的合成、表征及其抗癌性能研究。
J Inorg Biochem. 2012 Aug;113:77-82. doi: 10.1016/j.jinorgbio.2012.04.003. Epub 2012 Apr 12.

引用本文的文献

1
Os nuclear resonance scattering to explore hyperfine interactions and lattice dynamics for biological applications.利用核磁共振散射探索生物应用中的超精细相互作用和晶格动力学。
Sci Adv. 2025 Feb 7;11(6):eads3406. doi: 10.1126/sciadv.ads3406.
2
Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.基于过渡金属-芳烃体系的有机金属化合物作为抗癌剂的研究范围:从经典范式到靶向多种策略。
RSC Adv. 2019 Jan 24;9(6):3239-3278. doi: 10.1039/c8ra07926a. eCollection 2019 Jan 22.
3
Osmium Arene Germyl, Stannyl, Germanate, and Stannate Complexes as Anticancer Agents.
锇芳烃锗基、锡基、锗酸盐和锡酸盐配合物作为抗癌剂
ACS Omega. 2021 Jul 12;6(29):19252-19268. doi: 10.1021/acsomega.1c02665. eCollection 2021 Jul 27.
4
Polynuclear ruthenium organometallic compounds induce DNA damage in human cells identified by the nucleotide excision repair factor XPC.多核钌有机金属化合物通过核苷酸切除修复因子 XPC 诱导人细胞的 DNA 损伤。
Biosci Rep. 2019 Jul 15;39(7). doi: 10.1042/BSR20190378. Print 2019 Jul 31.
5
Polynuclear ruthenium organometallic complexes containing a 1,3,5-triazine ligand: synthesis, DNA interaction, and biological activity.多核钌有机金属配合物含 1,3,5-三嗪配体:合成、DNA 相互作用和生物活性。
J Biol Inorg Chem. 2018 Dec;23(8):1205-1217. doi: 10.1007/s00775-018-1599-8. Epub 2018 Jul 23.
6
Metal complexes in cancer therapy - an update from drug design perspective.癌症治疗中的金属配合物——从药物设计角度的最新进展
Drug Des Devel Ther. 2017 Mar 3;11:599-616. doi: 10.2147/DDDT.S119488. eCollection 2017.
7
Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction.具有抗癌作用的锇配合物抑制剂,靶向 HIF-1α 和 p300 蛋白-蛋白相互作用。
Sci Rep. 2017 Feb 22;7:42860. doi: 10.1038/srep42860.
8
Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands.含功能多样的2-苯基吡啶配体的半夹心铱(III)配合物的抗癌活性对比
Organometallics. 2015 Jun 8;34(11):2683-2694. doi: 10.1021/acs.organomet.5b00097. Epub 2015 Mar 25.
9
Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes.π-配位芳基对钌(II)糖基有机金属配合物抗癌活性的影响。
Front Chem. 2013 Oct 31;1:27. doi: 10.3389/fchem.2013.00027. eCollection 2013.
10
Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.双齿配体在锇(VI)氮化物配合物中控制细胞内靶向和细胞死亡途径。
J Am Chem Soc. 2013 Sep 25;135(38):14060-3. doi: 10.1021/ja4075375. Epub 2013 Sep 16.